ASTRAZEN

Astrazeneca Pharma India Share Price AstraZeneca Pharma India

₹5,328.45
13.7 (0.26%)
28 March, 2024 23:57 BSE: 506820 NSE: ASTRAZENISIN: INE203A01020

Start SIP in AstraZeneca Pharma India

Start SIP

Astrazeneca Pharma India Performance

Day Range

  • Low 5,255
  • High 5,380
₹ 5,328

52 Week Range

  • Low 3,098
  • High 7,221
₹ 5,328
  • Open Price5,330
  • Previous Close5,315
  • Volume7994

Astrazeneca Pharma India Share Price

  • Over 1 Month -3.34%
  • Over 3 Month -4.88%
  • Over 6 Month 19.27%
  • Over 1 Year 59.2%

Astrazeneca Pharma India Key Statistics

P/E Ratio 95.6
PEG Ratio 3.6
Market Cap Cr 13,321
Price to Book Ratio 22.6
EPS 50.5
Dividend 0.3
Relative Strength Index 50.01
Money Flow Index 48.31
MACD Signal -162
Average True Range 181.39
AstraZeneca Pharma India Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 306311295285
Operating Expenses Qtr Cr 291258228225
Operating Profit Qtr Cr 15536760
Depreciation Qtr Cr 4444
Interest Qtr Cr 1100
Tax Qtr Cr 521186
Net Profit Qtr Cr 16525417
IndicatorMar 2023
Total Revenue Annual Cr 1,029
Operating Expenses Annual Cr 838
Operating Profit Annual in Cr 165
Depreciation Cr 16
Interest Annual Cr 1
Tax Annual Cr 35
Net Profit Annual Cr 99
IndicatorMar 2023
Cash from Operating Activity Annual Cr 58
Cash from Investing Activity Annual Cr 18
Cash from Financing Annual Activity Cr -24
Net Cash Flow Annual Cr 52
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 589
Fixed Assets Annual Cr 70
Total Non Current Assets Annual Cr 149
Total Current Assets Annual Cr 835
Total Assets Annual Cr 985
IndicatorMar 2023
Book Value Per Share Annual Rs 235
ROE Annual % 17
ROCE Annual % 29
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 19
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual -
EBDIT Annual Margin %

Astrazeneca Pharma India Technicals

EMA & SMA

Current Price
₹5,328.45
13.7 (0.26%)
pointer
  • Bullish Moving Average
  • ___
  • 12
  • Bearish Moving Average
  • ___
  • 4
  • 20 Day
  • ₹5,263.08
  • 50 Day
  • ₹5,432.60
  • 100 Day
  • ₹5,310.69
  • 200 Day
  • ₹4,880.48
  • 20 Day
  • ₹5,242.67
  • 50 Day
  • ₹5,710.12
  • 100 Day
  • ₹5,398.37
  • 200 Day
  • ₹4,774.82

Astrazeneca Pharma India Resistance and Support

PIVOT
₹5,321.15
Resistance
First Resistance 5,387.30
Second Resistance 5,446.15
Third Resistance 5,512.30
RSI 50.01
MFI 48.31
MACD Single Line -162.00
MACD -122.93
Support
First Resistance 5,262.30
Second Resistance 5,196.15
Third Resistance 5,137.30

Astrazeneca Pharma India Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 9,003 374,615 41.61
Week 16,699 694,825 41.61
1 Month 15,198 873,907 57.5
6 Month 27,775 856,592 30.84

Astrazeneca Pharma India Result Highlights

AstraZeneca Pharma India Synopsis

NSE-Medical-Diversified

Astrazeneca Pharma I is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1002.97 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2023. AstraZeneca Pharma India Ltd. is a Public Limited Listed company incorporated on 11/07/1979 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L24231KA1979PLC003563 and registration number is 003563.
Market Cap 13,321
Sales 1,197
Shares in Float 0.63
No of funds 97
Yield 0.3
Book Value 22.35
U/D Vol ratio 0.7
LTDebt / Equity
Alpha 0.12
Beta 0.63

AstraZeneca Pharma India

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 75%75%75%75%
Mutual Funds 2.75%2.42%1.76%1.22%
Foreign Portfolio Investors 2.66%2.69%2.68%2.7%
Financial Institutions/ Banks
Individual Investors 17.09%17.44%18.12%18.46%
Others 2.5%2.45%2.44%2.62%

AstraZeneca Pharma India Management

Name Designation
Mr. Narayan K Seshadri Chairman & Ind.Director
Mr. Sanjeev Kumar Panchal Executive Director
Mr. Rajesh Marwaha Executive Director
Mr. Ankush Nandra Non Executive Director
Ms. Shilpa Shidhar Divekar Independent Director
Ms. Weiying Sarah Wang Non Executive Director
Ms. Revathy Ashok Independent Director

Astrazeneca Pharma India Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Astrazeneca Pharma India Corporate Action

Date Purpose Remarks
2024-02-08 Quarterly Results
2023-11-09 Quarterly Results
2023-08-14 Quarterly Results
2023-05-30 Audited Results & Dividend
2023-02-10 Quarterly Results
Date Purpose Remarks
2023-07-14 FINAL Rs.16.00 per share(800%)Dividend
2022-07-08 FINAL Rs.8.00 per share(400%)Final Dividend
2021-08-20 INTERIM Rs.2.00 per share(100%)Interim Dividend

AstraZeneca Pharma India FAQs

What is Share Price of AstraZeneca Pharma India ?

AstraZeneca Pharma India share price is ₹5,328 As on 28 March, 2024 | 23:43

What is the Market Cap of AstraZeneca Pharma India ?

The Market Cap of AstraZeneca Pharma India is ₹13321.1 Cr As on 28 March, 2024 | 23:43

What is the P/E ratio of AstraZeneca Pharma India ?

The P/E ratio of AstraZeneca Pharma India is 95.6 As on 28 March, 2024 | 23:43

What is the PB ratio of AstraZeneca Pharma India ?

The PB ratio of AstraZeneca Pharma India is 22.6 As on 28 March, 2024 | 23:43

Q2FY23